Voyong Fund
沃永基金
elsewhere's corpus does not cover Voyong Fund as a subject. The only material that names it describes a 2023 co-lead investment in PAM2L Biotechnologies' Pre-A round alongside Yunqi Capital and Fuhua Capital , but these are background mentions within articles published by 5Y Capital and Yunqi Capital — not profiles of Voyong Fund itself. No founding date, team, strategy, or fund size appears in the retrieved material.
AI-generated — may contain errors, please verify.
Voyong FundFund
沃永基金
渲染中…
Mentioned in 3 articles
Coverage
February: Returning to Our Imagination of the World | 5Y News Monthly
The big news from last month.
5Y News | Portfolio Company PAM2L Biotechnologies Closes Pre-A Round of Over 100 Million RMB
Leveraging synthetic biology and machine learning as dual engines to drive bio-based materials and product development.
"Bioyen Bio" Closes Over 100 Million Yuan Pre-A Round, Led by Yunqi Capital | Yunqi Capital
Leading research in materials synthetic biology, building an efficient innovation R&D platform
